Symposium:
092. When Transplantation Goes Viral: Mitigating CMV, Herpes, and HIV in Transplantation
Thursday, October 5, 2017: 2:00 PM-3:30 PM
Room: 06DE

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • review the strategies for the diagnosis, prevention and treatment of¬†cytomegalovirus infection after transplantation
  • describe the impact of herpes virus infections in transplantation.
  • discuss the current state of transplantation in HIV-infected persons.

Target Audience: Academicians, Clinicians, Fellows, Healthcare workers, HIV clinicians, HIV specialists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Researchers, Scientists

Tracks: Trainee, Adult ID, HIV-STD-TB, Pediatric ID


Moderators:  Raymund R. Razonable, MD, FIDSA, Mayo Clinic and Rachel Miller, MD, Duke University Medical Center

Presentations:
2:25 PM
877
When Other Herpesviruses Strike!
Danielle Zerr, MD, MPH, FPIDS

2:50 PM
878
Transplantation in HIV-Infected Persons
Emily Blumberg, MD, FIDSA

3:15 PM
Q&A

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-254-L01-P

Disclosures:

R. R. Razonable, None

R. Miller, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.